Screening mammography: The turning of the tide?

Current Oncology

Volumn 21, Issue 5, 2014, Pages 205-207

  Foulkes, W D ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER GRADING; CANCER GROWTH; CANCER SCREENING; CANCER SURVIVAL; EDITORIAL; HUMAN; MAMMOGRAPHY; MEDICAL SOCIETY; MORTALITY; PAGET NIPPLE DISEASE;

EID: 84907730750     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.21.2253     Document Type: Editorial

References (19)

1. Narod SA. Reflections on screening mammography and the early detection of breast cancer. Curr Oncol 2014;21:210-4.
2. Baum M. RE: Reflections on screening mammography and the early detection of breast cancer. Curr Oncol 2014;21:215-6.
3. O'Donoghue C, Eklund M, Ozanne EM, Esserman LJ. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med 2014;160:145.
4. Biller-Andorno N, Juni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med 2014;370:1965-7.
5. Smith RA, Kerlikowske K, Miglioretti DL, Kalager M. Clinical decisions. Mammography screening for breast cancer. N Engl J Med 2012;367:e31.
6. Tabár L, Fagerberg G, Day NE, Duffy SW, Kitchin RM. Natural history of breast cancer. Lancet 1992;339:1108.
7. Dunlap J, Le C, Shukla A, et al. Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma. Breast Cancer Res Treat 2010;120:409-18.
8. Zikan M, Bohm J, Pavlista D, Cibula D. Comparative analysis of loss of heterozygosity and expression profile in normal tissue, DCIS and invasive breast cancer. Clin Transl Oncol 2011;13:652-5.
9. Bernards R, Weinberg RA. A progression puzzle. Nature 2002;418:823.
10. Ding L, Ellis MJ, Li S, et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010;464:999-1005.
11. Collett K, Stefansson IM, Eide J, et al. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 2005;14:1108-12.
12. Zahl PH, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 2008;168:2311-16.
13. Tilanus-Linthorst MM, Kriege M, Boetes C, et al. Hereditary breast cancer growth rates and its impact on screening policy. Eur J Cancer 2005;41:1610-17.
14. Tabár L, Duffy SW, Vitak B, Chen HH, Prevost TC. The natural history of breast carcinoma: what have we learned from screening? Cancer 1999;86:449-62.
15. Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med 2014;174:448-54.
16. Welch HG, Frankel BA. Likelihood that a woman with screendetected breast cancer has had her "life saved" by that screening. Arch Intern Med 2011;171:2043-6.
17. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010;363:1203-10.
18. Roberts MM. Breast screening: time for a rethink? BMJ 1989;299:1153-5.
19. Biller-Andorno N. Cancer detection: breast-screening trials are ethical. Nature 2014;511:155.